Skip to content

Randomised clinical trial of the effects of total intravenous anaesthesia (TIVA: propofol) versus volatile anaesthesia (sevoflurane-N20 induction and isoflurane-N20 maintenance) on children’s post-operative cognition, behaviour and physical morbidity. - Cognition GA Study

Randomised clinical trial of the effects of total intravenous anaesthesia (TIVA: propofol) versus volatile anaesthesia (sevoflurane-N20 induction and isoflurane-N20 maintenance) on children’s post-operative cognition, behaviour and physical morbidity. - Cognition GA Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-005742-37-GB
Enrollment
360
Registered
2007-01-02
Start date
2007-01-26
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental caries MedDRA version: 8.1 Level: LLT Classification code 10012318 Term: Dental caries

Interventions

Trade Name: Propofol-Lipuro 1% Product Name: Propofol Pharmaceutical Form: Intravenous infusion INN or Proposed INN: PROPOFOL CAS Number

Sponsors

NHS Glasgow and Clyde / University of Glasgow
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Male and female children aged 5 - 14 years Require general anaesthesia for multiple dental extractions and restorations Fitness ASA class 1 or 2 Written informed consent of parent/ legal guardian Written assent from child if appropriate Able to undertake psychometric assessment tests Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: English not first language Learning disability Psychiatric condition ASA fitness class 3 -5 Neurological disorder Sensory impairment No consent from parent/legal guardian Allergy to propofol or it's excipients Recent general anaesthesia within 3 weeks Medical comorbidity which would contraindicate general anaesthesia (eg active infection, difficult airway) Medical comorbidity which would contraindicate use of volatile agents (eg malignant hyperthermia susceptibility)

Design outcomes

Primary

MeasureTime frame
Main Objective: Comparison of cognitive function and emotional well-being after either Total Intravenous Anaesthesia (TIVA) with propofol or volatile anaesthesia with nitrous oxide and sevoflurane induction of anaesthesia followed by nitrous oxide and isoflurane maintenance of anaesthesia.; Secondary Objective: Dose requirements to achieve and maintain a standardised depth of anaesthesia as indicated by auditory evoked potentials. Recovery rate and quality of recovery ; Primary end point(s): Cognitive function assessments: Choice reaction time, Wechsler Intelligence Scale for Children, Rivermead Behavioural Memory Test for Children Behavioural and emotional assessments: Revised Rutter Scale for School-Age Children, Child Impact of Events Scale Assessments are carried out pre-operatively, 1h postoperatively, at 24 hours and at 1 week.

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026